CAS 2188-18-3
:N2-[(1,1-Dimetiletoxicarbonil)]-N5-[imino(nitroamino)metil]-L-ornitina
- (2S)-2-(tert-Butoxycarbonylamino)-5-[(N-nitrocarbamimidoyl)amino]pentanoic acid
- (2S)-2-[[(tert-Butoxy)carbonyl]amino]-5-(N′-nitrocarbamimidamido)pentanoic acid
- (2S)-5-[Amino(nitramido)methylidene]azaniumyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate
- <span class="text-smallcaps">L</span>-Ornithine, N<sup>2</sup>-[(1,1-dimethylethoxy)carbonyl]-N<sup>5</sup>-[imino(nitroamino)methyl]-
- Boc-Arg(NO2)-OH
- Boc-Arg(No2)
- Boc-L-nitroarginine
- N-Boc-N'-nitro-L-arginine
- N<sup>2</sup>-[(1,1-Dimethylethoxy)carbonyl]-N<sup>5</sup>-[imino(nitroamino)methyl]-<span class="text-smallcaps">L</span>-ornithine
- N<sup>2</sup>-tert-Butoxycarbonyl-N<sup>G</sup>-nitroarginine
- N<sup>2</sup>-tert-Butyloxycarbonyl-N<sup>ω</sup>-nitro-<span class="text-smallcaps">L</span>-arginine
- N<sup>α</sup>-tert-Butoxycarbonyl-N<sup>G</sup>-nitro-<span class="text-smallcaps">L</span>-arginine
- N<sup>α</sup>-tert-Butoxycarbonyl-N<sup>G</sup>-nitroarginine
- Ornithine, N<sup>2</sup>-carboxy-N<sup>5</sup>-(nitroamidino)-, N-tert-butyl ester
- Ornithine, N<sup>2</sup>-carboxy-N<sup>5</sup>-(nitroamidino)-, N<sup>2</sup>-tert-butyl ester, <span class="text-smallcaps">L</span>-
- Nα-tert-Butoxycarbonyl-NG-nitro-L-arginine
- Ornithine, N2-carboxy-N5-(nitroamidino)-, N-tert-butyl ester
- N2-[(1,1-Dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-L-ornithine
- L-Ornithine, N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-
- Ver más sinónimos
Nα-Boc-N^w-nitro-L-arginine, 98%
CAS:This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Sci
Fórmula:C11H21N5O6Pureza:98%Peso molecular:319.32Boc-Arg(NO₂)-OH
CAS:The nitro group of the guanidyl residue can be removed by treating the blocked peptide with HF at 0 °C for 40 min.Fórmula:C11H21N5O6Pureza:> 99%Forma y color:White PowderPeso molecular:319.32N-α-BOC-N-ω-Nitro-L-arginine
CAS:N-α-BOC-N-ω-Nitro-L-arginineFórmula:C11H21N5O6Pureza:98%Forma y color: off-white solidPeso molecular:319.31g/molBoc-Arg(NO2)-OH
CAS:Fórmula:C11H21N5O6Pureza:>98.0%(T)(HPLC)Forma y color:White to Light yellow powder to crystalPeso molecular:319.32Boc-L-Nitroarginine
CAS:Producto controladoApplications Boc-L-Nitroarginine, can be used in peptide chemistry. It has been also shown to act as NO synthase inhibitor, and thus used in the study of The effects of methylene blue (MB) for treatment of sepsis induced by bowel perforation.
References Galili, Y. Euro. surg. Rese. vol. 29, P:390-395 (19997);Fórmula:C11H21N5O6Forma y color:NeatPeso molecular:319.31BOC-Nitro-L-Arginine extrapure, 99%
CAS:Fórmula:C11H21N5O6Pureza:min. 99%Forma y color:White, PowderPeso molecular:319.31Boc-Arg(NO2)-OH
CAS:M03259 - Boc-Arg(NO2)-OH
Fórmula:C11H21N5O6Pureza:95%Forma y color:SolidPeso molecular:319.318Boc-Arg(NO2)-OH
CAS:Boc-Arg(NO2)-OH is an activated molecule that is used as an anticoagulant. It inhibits the serine protease, which has an inhibitory effect on heparin-induced thrombocytopenia, and also inhibits platelet aggregation. Boc-Arg(NO2)-OH has been shown to have a potent inhibition of the enzyme that converts prothrombin into thrombin. This effect can be reversed by adding protamine sulfate. The clinical data suggest that this drug may be beneficial for patients with severe or life-threatening conditions who are taking heparin therapy or undergoing surgery and need anticoagulation. The prognosis of this drug is unclear, but it appears to be safe when administered in conjunction with other medications such as aspirin and warfarin.
Fórmula:C10H19NO4Pureza:Min. 95%Peso molecular:319.32 g/molBoc-L-Nitroarginine
CAS:Boc-L-Nitroarginine is a nitric oxide synthase inhibitor that belongs to the class of drugs called nitric oxide inhibitors. It is a potent inhibitor of nitric oxide synthase, preventing the production of nitric oxide from arginine. The drug has been shown to have therapeutic effects in the treatment of cancer, diabetes mellitus, and other diseases. Boc-L-Nitroarginine inhibits tumor angiogenesis by blocking endothelial cell proliferation and migration. It also inhibits insulin secretion, leading to an improved glycemic control in diabetic patients. Boc-L-Nitroarginine can be used as a hydrogenation reducing agent for the synthesis of imatinib and palladium catalysts for hydrogenation reactions.
Fórmula:C11H21N5O6Pureza:Min. 95%Forma y color:PowderPeso molecular:319.31 g/molRef: 3D-FB39246
Producto descatalogado











